{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T09:51:23Z","timestamp":1791280283516,"version":"4.1.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,4,1]],"date-time":"2004-04-01T00:00:00Z","timestamp":1080777600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.urology.2003.11.049","type":"journal-article","created":{"date-parts":[[2004,4,13]],"date-time":"2004-04-13T09:31:41Z","timestamp":1081848701000},"page":"682-686","source":"Crossref","is-referenced-by-count":375,"title":["Intravesical bacille calmette-gu\u00e9rin versus mitomycin c in superficial bladder cancer: formal meta-analysis of comparative studies on tumor progression"],"prefix":"10.1016","volume":"63","author":[{"given":"A","family":"B\u00f6hle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.R","family":"Bock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2003.11.049_BIB1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0022-5347(17)51695-X","article-title":"Superficial bladder cancer","volume":"130","author":"Heney","year":"1983","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB2","first-page":"254","article-title":"The T1 bladder tumor","volume":"8","author":"Herr","year":"1990","journal-title":"Semin Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB3","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0022-5347(05)64043-8","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin versus mitomycin C for superficial bladder cancer","volume":"169","author":"B\u00f6hle","year":"2003","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-5347(05)67972-4","article-title":"Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors","volume":"163","author":"Herr","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB5","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)67707-5","article-title":"Maintenance bacillus Calmette-Gu\u00e9rin immunotherapy for recurrent TA, T1 and carcinoma in situ transitional cell carcinoma of the bladder","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB6","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/S0022-5347(17)39368-0","article-title":"Comparison of different schedules of cytostatic intravesical instillations in patients with superficial bladder carcinoma","volume":"144","author":"Huland","year":"1990","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB7","series-title":"Cochrane Reviewers' Handbook, version 4.0","author":"Clarke","year":"2000"},{"key":"10.1016\/j.urology.2003.11.049_BIB8","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0302-2838(01)00026-4","article-title":"Guidelines on bladder cancer","volume":"41","author":"Oosterlinck","year":"2002","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/1078-1439(95)00041-F","article-title":"Randomized intergroup comparison of bacillus Calmette-Gu\u00e9rin immunotherapy and mitomycin C chemotherapy prophylaxis in superficial transitional cell carcinoma of the bladder","volume":"1","author":"Lamm","year":"1995","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2003.11.049_BIB10","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Nat Cancer Inst"},{"key":"10.1016\/j.urology.2003.11.049_BIB11","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.1016\/S0022-5347(01)65396-5","article-title":"A combined analysis of European Organization for Research and Treatment of Cancer and Medical Research Council randomized clinical trials for the prophylactic treatment of stage TaT1 bladder cancer","volume":"156","author":"Pawinski","year":"1996","journal-title":"J Urol"},{"issue":"suppl","key":"10.1016\/j.urology.2003.11.049_BIB12","first-page":"673","article-title":"Intravesical prophylaxis in bladder cancer","volume":"163","author":"Lamm","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1046\/j.1464-410x.2001.02306.x","article-title":"A systematic review of intravesical BCG plus transurethral resection vs. transurethral resection alone in TA and T1 bladder cancer","volume":"88","author":"Shelley","year":"2001","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2003.11.049_BIB14","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1016\/S0022-5347(05)68208-0","article-title":"Bladder Cancer Clinical Guidelines Panel summary report on the management of nonmuscle invasive bladder cancer (stages Ta, T1 and Tis)","volume":"162","author":"Smith","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB15","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1016\/S0022-5347(05)64273-5","article-title":"Intravesical bacillus Calmette-Gu\u00e9rin reduces the risk of progression in patients with superficial bladder cancer","volume":"168","author":"Sylvester","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB16","first-page":"206","article-title":"R\u00e9sultats du BCG dans le traitement des tumeurs de vessie pTa et pT1. Evaluation d'un protocole long utilisant 75 mg de BCG de souche Pasteur","volume":"8","author":"Ayed","year":"1998","journal-title":"Prog Urol"},{"issue":"suppl","key":"10.1016\/j.urology.2003.11.049_BIB17","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/0090-4295(92)90530-A","article-title":"Bacillus Calmette-Gu\u00e9rin versus mitomycin C intravesical therapy in superficial bladder cancer","volume":"40","author":"Debruyne","year":"1992","journal-title":"Urology"},{"key":"10.1016\/j.urology.2003.11.049_BIB18","series-title":"Immunotherapy of Urological Tumors","first-page":"13","article-title":"Immunotherapy (BCG) versus chemotherapy (MMC) in intravesical treatment of superficial urinary bladder cancer","author":"Jauhiainen","year":"1989"},{"key":"10.1016\/j.urology.2003.11.049_BIB19","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1016\/S0022-5347(01)65673-8","article-title":"A randomized multicenter trial of adjuvant therapy in superficial bladder cancer","volume":"156","author":"Krege","year":"1996","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB20","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(01)61607-0","article-title":"5-year follow-up of a randomized prospective study comparing mitomycin C and bacillus Calmette-Gu\u00e9rin in patients with superficial bladder carcinoma","volume":"161","author":"Malmstr\u00f6m","year":"1999","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/S0022-5347(05)67975-X","article-title":"Multivariate analysis of the prognostic factors of primary superficial bladder cancer","volume":"163","author":"Mill\u00e9n-Rodr\u00edguez","year":"2000","journal-title":"J Urol"},{"issue":"suppl 2","key":"10.1016\/j.urology.2003.11.049_BIB22","first-page":"447","article-title":"A multicenter randomized prospective study comparing three intravesical therapies, two with bacillus Calmette-Gu\u00e9rin immunotherapy and one with mitomycin C chemotherapy in medium and low risk superficial bladder tumors","volume":"37","author":"Nogueira","year":"2000","journal-title":"Eur Urol"},{"key":"10.1016\/j.urology.2003.11.049_BIB23","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/S0022-5347(01)67606-7","article-title":"A randomized study of intravesical mitomycin C, bacillus Calmette-Gu\u00e9rin TICE and bacillus Calmette-Gu\u00e9rin RIVM treatment in pTa-pT1 papillary carcinoma and carcinoma in situ of the bladder","volume":"153","author":"Vegt","year":"1995","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429504001475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0090429504001475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T03:53:13Z","timestamp":1550116393000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0090429504001475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":23,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0090429504001475"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2003.11.049","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}